Alain Munoz
Président chez ACTICOR BIOTECH SAS
Fortune : 1 M $ au 30/04/2024
Profil
Alain H.
Munoz founded Amistad Pharma in 2000, where he is working as Chief Executive Officer from 2009.
Dr. Munoz also founded Science, Business & Management SARL, where he is working as Chief Executive Officer.
Dr. Munoz also currently works at Acticor Biotech SAS, as Chairman from 2021, Auris Medical AG, as Director from 2018, Altamira Therapeutics Ltd., as Independent Non-Executive Director from 2018, and various other companies.
Dr. Munoz also formerly worked at Novagali Pharma SA, as Chairman-Supervisory Board from 2003 to 2011, Key Neurosciences SAS, as Chairman, Hybrigenics SA, as Director from 2017 to 2019, and various other companies.
Dr. Munoz received his doctorate degree from Université de Montpellier, undergraduate degree from International Institute for Management Development, and graduate degree from Centre Hospitalier Universitaire Pitie-Salpetriere.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEALAND PHARMA A/S
0,02% | 31/12/2023 | 12 215 ( 0,02% ) | 1 M $ | 30/04/2024 |
| 29/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Alain Munoz
| Sociétés | Poste | Début |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Directeur/Membre du Conseil | 01/03/2018 |
| ACTICOR BIOTECH SAS | Président | 15/06/2021 |
| AMRYT PHARMA PLC | Directeur/Membre du Conseil | 24/09/2019 |
| Science, Business & Management SARL | Directeur Général | - |
| Intercell Austria AG | Directeur/Membre du Conseil | - |
| Amistad Pharma | Directeur Général | 01/01/2000 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Directeur/Membre du Conseil | 01/03/2018 |
Anciens postes connus de Alain Munoz
| Sociétés | Poste | Fin |
|---|---|---|
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 20/03/2024 |
| CELLECTIS S.A. | Directeur/Membre du Conseil | 31/12/2022 |
| ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Alain Munoz
| International Institute for Management Development | Undergraduate Degree |
| Centre Hospitalier Universitaire Pitie-Salpetriere | Graduate Degree |
| Université de Montpellier | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 11 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| ASARINA PHARMA AB | Health Technology |
| SANOFI | Health Technology |
| ATON | Health Technology |
| CELLECTIS S.A. | Health Technology |
| ADOCIA | Health Technology |
| VALERIO THERAPEUTICS | Health Technology |
| VALNEVA | Health Technology |
| MEDESIS PHARMA S.A. | Health Technology |
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| ACTICOR BIOTECH SAS | Health Technology |
| Entreprise privées | 23 |
|---|---|
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Saint Jean Industries Lorraine SAS
 Saint Jean Industries Lorraine SAS Metal FabricationProducer Manufacturing Saint Jean Industries Lorraine SAS specializes in the design and the production of prototype parts. The firm offers molded housings for the automotive, hydraulic components and agro alimentary industries. The company was founded in 1983 and is headquartered in Harol, France. | Producer Manufacturing |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
GeneSystems SA
 GeneSystems SA Pharmaceuticals: MajorHealth Technology GeneSystems SA develops and commercializes innovative identification and detection products for proteins. The company develops innovative proteomics products that allow drug companies and life scientists to obtain a digital snapshot of the protein-signaling pathways in disease samples. This snapshot allows drug therapies to be personalized for patients. GeneSystems was founded in 2000 and is headquartered in Bruz, France. | Health Technology |
| Amistad Pharma | |
| Medesis SA | |
Genticel SA
 Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Health Technology |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Vivacta Ltd.
 Vivacta Ltd. Medical SpecialtiesHealth Technology Vivacta Ltd. operates as a medical diagnostics company. It develop point of care diagnostic device and microfluidic cartridge. The company is founded in 2005 and is headquartered in Camberley, the United Kingdom. | Health Technology |
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
| Intercell Austria AG | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Health Technology |
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
| Science, Business & Management SARL | |
Fournier Laboratories Ireland Ltd.
 Fournier Laboratories Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Fournier Laboratories Ireland Ltd. is an Irish company that manufactures pharmaceutical preparations. The company is based in Carrigtwohill, Ireland. | Health Technology |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Commercial Services |
Fournier Group, Inc.
 Fournier Group, Inc. Multi-Line InsuranceFinance Part of RSC Insurance Brokerage, Inc., Fournier Group, Inc. is a dynamic independent insurance agency headquartered in Portland, OR. Fournier Group, Inc. provides personal (home/auto/specialty), business, and aviation insurance to diverse clients. The company was founded by Dirk Fournier. Fournier Group was acquired by RSC Insurance Brokerage, Inc. on December 09, 2021. | Finance |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
